US5916891A
(en)
|
1992-01-13 |
1999-06-29 |
Smithkline Beecham Corporation |
Pyrimidinyl imidazoles
|
KR19980701374A
(ko)
*
|
1995-01-12 |
1998-05-15 |
스티븐 베네티아너 |
신규 화합물(Novel Compounds)
|
US6369068B1
(en)
|
1995-06-07 |
2002-04-09 |
Smithkline Beecham Corporation |
Amino substituted pyrimidine containing compounds
|
US5658903A
(en)
|
1995-06-07 |
1997-08-19 |
Smithkline Beecham Corporation |
Imidazole compounds, compositions and use
|
US5739143A
(en)
*
|
1995-06-07 |
1998-04-14 |
Smithkline Beecham Corporation |
Imidazole compounds and compositions
|
ZA9610687B
(en)
*
|
1995-12-22 |
1997-09-29 |
Smithkline Beecham Corp |
Novel synthesis.
|
AP9700912A0
(en)
*
|
1996-01-11 |
1997-01-31 |
Smithkline Beecham Corp |
Novel cycloalkyl substituted imidazoles
|
ES2205167T3
(es)
*
|
1996-01-11 |
2004-05-01 |
Smithkline Beecham Corporation |
Nuevos compuestos de imidazol sustituidos.
|
ZA97175B
(en)
*
|
1996-01-11 |
1997-11-04 |
Smithkline Beecham Corp |
Novel substituted imidazole compounds.
|
US6046208A
(en)
*
|
1996-01-11 |
2000-04-04 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
JP2000507224A
(ja)
*
|
1996-03-08 |
2000-06-13 |
スミスクライン・ビーチャム・コーポレイション |
Csaid化合物の血管形成の抑制物質としての使用
|
EP0889887A4
(de)
*
|
1996-03-25 |
2003-06-11 |
Smithkline Beecham Corp |
Behandlung von verletzungen des zentralen nervensystems
|
WO1997035856A1
(en)
*
|
1996-03-25 |
1997-10-02 |
Smithkline Beecham Corporation |
Novel treatment for cns injuries
|
WO1998007425A1
(en)
|
1996-08-21 |
1998-02-26 |
Smithkline Beecham Corporation |
Imidazole compounds, compositions and use
|
AU5147598A
(en)
*
|
1996-10-17 |
1998-05-11 |
Smithkline Beecham Corporation |
Methods for reversibly inhibiting myelopoiesis in mammalian tissue
|
ZA9711092B
(en)
*
|
1996-12-11 |
1999-07-22 |
Smithkline Beecham Corp |
Novel compounds.
|
US6020357A
(en)
*
|
1996-12-23 |
2000-02-01 |
Dupont Pharmaceuticals Company |
Nitrogen containing heteroaromatics as factor Xa inhibitors
|
US6548512B1
(en)
|
1996-12-23 |
2003-04-15 |
Bristol-Myers Squibb Pharma Company |
Nitrogen containing heteroaromatics as factor Xa inhibitors
|
US5929076A
(en)
*
|
1997-01-10 |
1999-07-27 |
Smithkline Beecham Corporation |
Cycloalkyl substituted imidazoles
|
US6979686B1
(en)
|
2001-12-07 |
2005-12-27 |
Pharmacia Corporation |
Substituted pyrazoles as p38 kinase inhibitors
|
US6514977B1
(en)
*
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
JP2002502380A
(ja)
*
|
1997-05-22 |
2002-01-22 |
ジー.ディー.サール アンド カンパニー |
p38キナーゼ阻害剤としてのピラゾール誘導体
|
CA2294057A1
(en)
|
1997-06-13 |
1998-12-17 |
Smithkline Beecham Corporation |
Novel pyrazole and pyrazoline substituted compounds
|
CA2294137A1
(en)
|
1997-06-19 |
1998-12-23 |
Smithkline Beecham Corporation |
Novel aryloxy substituted pyrimidine imidazole compounds
|
US6339099B1
(en)
|
1997-06-20 |
2002-01-15 |
Dupont Pharmaceuticals Company |
Guanidine mimics as factor Xa inhibitors
|
US6562832B1
(en)
|
1997-07-02 |
2003-05-13 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
US7301021B2
(en)
|
1997-07-02 |
2007-11-27 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
AR016294A1
(es)
*
|
1997-07-02 |
2001-07-04 |
Smithkline Beecham Corp |
Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
|
US6489325B1
(en)
|
1998-07-01 |
2002-12-03 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
AU8381098A
(en)
|
1997-07-02 |
1999-01-25 |
Smithkline Beecham Corporation |
Novel cycloalkyl substituted imidazoles
|
TW517055B
(en)
|
1997-07-02 |
2003-01-11 |
Smithkline Beecham Corp |
Novel substituted imidazole compounds
|
EP1041989A4
(de)
|
1997-10-08 |
2002-11-20 |
Smithkline Beecham Corp |
Neue cycloalkenyl substituierte verbindungen
|
WO1999018942A1
(en)
*
|
1997-10-10 |
1999-04-22 |
Imperial College Innovations Ltd. |
Use of csaidtm compounds for the management of uterine contractions
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
AU1053399A
(en)
*
|
1997-11-14 |
1999-06-07 |
Sankyo Company Limited |
Pyridylpyrrole derivatives
|
AU1924699A
(en)
|
1997-12-19 |
1999-07-12 |
Smithkline Beecham Corporation |
Compounds of heteroaryl substituted imidazole, their pharmaceutical compositionsand uses
|
US20080300281A1
(en)
*
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
US7517880B2
(en)
*
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
US6340685B1
(en)
|
1998-05-22 |
2002-01-22 |
Scios, Inc. |
Compounds and methods to treat cardiac failure and other disorders
|
US6130235A
(en)
*
|
1998-05-22 |
2000-10-10 |
Scios Inc. |
Compounds and methods to treat cardiac failure and other disorders
|
US6589954B1
(en)
|
1998-05-22 |
2003-07-08 |
Scios, Inc. |
Compounds and methods to treat cardiac failure and other disorders
|
US6448257B1
(en)
|
1998-05-22 |
2002-09-10 |
Scios, Inc. |
Compounds and methods to treat cardiac failure and other disorders
|
US6867209B1
(en)
|
1998-05-22 |
2005-03-15 |
Scios, Inc. |
Indole-type derivatives as inhibitors of p38 kinase
|
CN1302296A
(zh)
|
1998-05-22 |
2001-07-04 |
史密丝克莱恩比彻姆公司 |
新的2-烷基取代咪唑化合物
|
US6858617B2
(en)
|
1998-05-26 |
2005-02-22 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
US6207687B1
(en)
*
|
1998-07-31 |
2001-03-27 |
Merck & Co., Inc. |
Substituted imidazoles having cytokine inhibitory activity
|
EP1112070B1
(de)
*
|
1998-08-20 |
2004-05-12 |
Smithkline Beecham Corporation |
Neue substituierte triazolverbindungen
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
MXPA01002173A
(es)
|
1998-08-28 |
2003-07-14 |
Scios Inc |
Inhibidores de p38-alfa cinasa.
|
ATE336484T1
(de)
|
1998-08-29 |
2006-09-15 |
Astrazeneca Ab |
Pyrimidine verbindungen
|
ES2274634T3
(es)
|
1998-08-29 |
2007-05-16 |
Astrazeneca Ab |
Compuestos de pirimidina.
|
AU6476599A
(en)
*
|
1998-11-03 |
2000-05-22 |
Novartis Ag |
Anti-inflammatory 4-phenyl-5-pyrimidinyl-imidazoles
|
ES2212657T3
(es)
*
|
1998-11-04 |
2004-07-16 |
Smithkline Beecham Corporation |
Pirazinas sustituidas piridin-4-il o pirimidin-4-il.
|
US6239279B1
(en)
|
1998-12-16 |
2001-05-29 |
Smithkline Beecham Corporation |
Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
IL144144A0
(en)
|
1999-01-13 |
2002-05-23 |
Bayer Ag |
Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
|
WO2000042012A1
(en)
*
|
1999-01-13 |
2000-07-20 |
Bayer Corporation |
φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
ME00275B
(me)
*
|
1999-01-13 |
2011-02-10 |
Bayer Corp |
ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
|
UA73492C2
(en)
*
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
MXPA01008440A
(es)
|
1999-02-22 |
2002-04-24 |
Boehringer Ingelheim Pharma |
Derivados heterociclicos policiclos como agentes anti-inflamatorios..
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
MXPA01009077A
(es)
|
1999-03-12 |
2002-03-27 |
Boehringer Ingelheim Pharma |
Composiciones heterociclicos aromaticos como agentes anti-inflamatorios.
|
DE60014603T2
(de)
|
1999-03-12 |
2006-02-16 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
Heterocyklischer harnstoff und verwandte verbindungen als entzündungshemmende mittel
|
GB9907658D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Chemical compounds
|
CO5170501A1
(es)
*
|
1999-04-14 |
2002-06-27 |
Novartis Ag |
AZOLES SUSTITUIDOS UTILES PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR TNFa eIL-1 Y ENFERMEDADES DEL METABOLISMO OSEO
|
US6930101B1
(en)
|
1999-05-17 |
2005-08-16 |
The Regents Of The University Of California |
Thiazolopyrimidines useful as TNFα inhibitors
|
IL146309A
(en)
|
1999-05-21 |
2008-03-20 |
Scios Inc |
Derivatives of the indole type and pharmaceutical preparations containing them as inhibitors of kinase p38
|
ATE312823T1
(de)
|
1999-07-09 |
2005-12-15 |
Boehringer Ingelheim Pharma |
Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen
|
US7122666B2
(en)
*
|
1999-07-21 |
2006-10-17 |
Sankyo Company, Limited |
Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
|
GB9919778D0
(en)
*
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
US6541477B2
(en)
|
1999-08-27 |
2003-04-01 |
Scios, Inc. |
Inhibitors of p38-a kinase
|
CA2385722A1
(en)
*
|
1999-09-17 |
2001-03-22 |
Smithkline Beecham Corporation |
Use of csaids in rhinovirus infection
|
ES2254238T3
(es)
*
|
1999-10-27 |
2006-06-16 |
Novartis Ag |
Compuestos de tiazol e imidazo(4,5-b)piridina y su uso farmaceutico.
|
US6982270B1
(en)
|
1999-11-23 |
2006-01-03 |
Smithkline Beecham Corporation |
3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors
|
AU1781601A
(en)
|
1999-11-23 |
2001-06-04 |
Smithkline Beecham Corporation |
3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
|
WO2001038314A1
(en)
|
1999-11-23 |
2001-05-31 |
Smithkline Beecham Corporation |
3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
|
US6759410B1
(en)
*
|
1999-11-23 |
2004-07-06 |
Smithline Beecham Corporation |
3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
|
BR0008060A
(pt)
*
|
1999-12-08 |
2002-02-05 |
Pharmacia Corp |
Composições inibidoras de ciclooxigenase-2 tendo rápido inìcio de eficácia terapêutica
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004887D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004886D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
US7235551B2
(en)
*
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
GB0007371D0
(en)
|
2000-03-28 |
2000-05-17 |
Astrazeneca Uk Ltd |
Chemical compounds
|
IL151877A0
(en)
*
|
2000-03-30 |
2003-04-10 |
Shionogi & Co |
A process for producing imidazopyridine derivatives and a crystal form of an imidazopyridine derivative
|
GB0016877D0
(en)
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Chemical compounds
|
WO2002005848A2
(en)
*
|
2000-07-13 |
2002-01-24 |
Pharmacia Corporation |
Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
|
PE20020506A1
(es)
*
|
2000-08-22 |
2002-07-09 |
Glaxo Group Ltd |
Derivados de pirazol fusionados como inhibidores de la proteina cinasa
|
GB0021726D0
(en)
|
2000-09-05 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
MXPA03003612A
(es)
*
|
2000-10-23 |
2003-06-19 |
Smithkline Beecham Corp |
Compuestos novedosos.
|
US6670357B2
(en)
*
|
2000-11-17 |
2003-12-30 |
Bristol-Myers Squibb Company |
Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
|
US6867300B2
(en)
*
|
2000-11-17 |
2005-03-15 |
Bristol-Myers Squibb Company |
Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
|
CA2429605A1
(en)
|
2000-11-20 |
2002-05-30 |
Scios Inc. |
Indol derivative and their use as inhibitors of p38 kinase
|
DE60125980T2
(de)
|
2000-11-20 |
2007-10-25 |
Scios Inc., Sunnyvale |
P38kinase-inhibitoren vom piperidin/piperazin-typ
|
CA2429382A1
(en)
*
|
2000-11-20 |
2002-06-06 |
Scios Inc. |
Indole-type inhibitors of p38 kinase
|
US7115565B2
(en)
*
|
2001-01-18 |
2006-10-03 |
Pharmacia & Upjohn Company |
Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
|
US7199124B2
(en)
*
|
2001-02-02 |
2007-04-03 |
Takeda Pharmaceutical Company Limited |
JNK inhibitor
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
ATE309997T1
(de)
*
|
2001-03-09 |
2005-12-15 |
Pfizer Prod Inc |
Entzündungshemmende benzimidazolverbindungen
|
PE20021017A1
(es)
|
2001-04-03 |
2002-11-24 |
Pharmacia Corp |
Composicion parenteral reconstituible
|
WO2002094267A1
(fr)
*
|
2001-05-24 |
2002-11-28 |
Sankyo Company, Limited |
Preparation pharmaceutique pour prevenir ou traiter l'arthrite
|
GB0113041D0
(en)
|
2001-05-30 |
2001-07-18 |
Astrazeneca Ab |
Chemical compounds
|
US7076539B2
(en)
*
|
2001-07-30 |
2006-07-11 |
Hewlett-Packard Development Company, L.P. |
Network connectivity establishment at user log-in
|
UA80682C2
(en)
*
|
2001-08-06 |
2007-10-25 |
Pharmacia Corp |
Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
|
GB0124932D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
GB0124933D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
GB0124931D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
GB0124934D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
GB0124939D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
GB0124941D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
GB0124938D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
GB0124936D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
ATE550332T1
(de)
*
|
2001-10-22 |
2012-04-15 |
Mitsubishi Tanabe Pharma Corp |
4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors
|
ATE420671T1
(de)
*
|
2001-10-25 |
2009-01-15 |
Univ Connecticut |
Fibroinzusammensetzungen und verfahren zu deren herstellung
|
EP2277552A1
(de)
*
|
2001-10-29 |
2011-01-26 |
Boehringer Ingelheim International GmbH |
Mnk kinase proteine und diabetes
|
WO2003068229A1
(en)
|
2002-02-11 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
|
CA2475703C
(en)
|
2002-02-11 |
2016-12-20 |
Bayer Pharmaceuticals Corporation |
Aryl ureas with angiogenesis inhibiting activity
|
SI1474395T1
(sl)
|
2002-02-12 |
2008-02-29 |
Smithkline Beecham Corp |
Nikotinamidni derivati, uporabni kot inhibitorji p38
|
JP4629978B2
(ja)
|
2002-02-25 |
2011-02-09 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
サイトカイン媒介疾患の治療に有用な1,4−二置換ベンゾ縮合シクロアルキル尿素化合物
|
GB0205688D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
GB0205693D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
WO2003076434A1
(en)
|
2002-03-09 |
2003-09-18 |
Astrazeneca Ab |
4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
|
GB0205690D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
AR039241A1
(es)
*
|
2002-04-04 |
2005-02-16 |
Biogen Inc |
Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
|
PL219736B1
(pl)
|
2002-04-23 |
2015-07-31 |
Bristol Myers Squibb Co |
Pochodna pirolotriazynoaniliny, kompozycja farmaceutyczna i jej zastosowanie
|
EP1534282B1
(de)
|
2002-07-09 |
2006-12-27 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
|
GB0217757D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Novel compounds
|
WO2004014900A1
(en)
*
|
2002-08-09 |
2004-02-19 |
Eli Lilly And Company |
Benzimidazoles and benzothiazoles as inhibitors of map kinase
|
EP1539121A4
(de)
*
|
2002-08-29 |
2008-08-13 |
Scios Inc |
Verfahren zur forderung der osteogenese
|
AU2003268464A1
(en)
|
2002-09-03 |
2004-03-29 |
Scios Inc. |
INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
|
UA80296C2
(en)
*
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Imidazolopyridines and methods of making and using the same
|
UA80295C2
(en)
*
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Pyrazolopyridines and using the same
|
PL376374A1
(en)
|
2002-10-09 |
2005-12-27 |
Scios Inc. |
Azaindole derivatives as inhibitors of p38 kinase
|
CL2004000234A1
(es)
*
|
2003-02-12 |
2005-04-15 |
Biogen Idec Inc |
Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
GB0308185D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
GB0308186D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
GB0308201D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
GB0308466D0
(en)
*
|
2003-04-11 |
2003-05-21 |
Novartis Ag |
Organic compounds
|
GB0311274D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
GB0311276D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
US20070020704A1
(en)
|
2003-05-20 |
2007-01-25 |
Scott Wilhelm |
Diaryl ureas with kinase inhibiting activity
|
US7652044B2
(en)
*
|
2003-06-03 |
2010-01-26 |
Novartis A.G. |
P-38 inhibitors
|
SI2298743T1
(sl)
|
2003-06-26 |
2012-12-31 |
Novartis Ag |
Inhibitorji p38-kinaze na osnovi 5-ÄŤlenskih heterociklov
|
US7105467B2
(en)
*
|
2003-07-08 |
2006-09-12 |
Pharmacore, Inc. |
Nickel catalyzed cross-coupling reactions between organomagnesium compounds and anisole derivatives
|
NZ580384A
(en)
|
2003-07-23 |
2011-03-31 |
Bayer Pharmaceuticals Corp |
4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
|
WO2005012241A2
(en)
*
|
2003-07-25 |
2005-02-10 |
Novartis Ag |
p-38 KINASE INHIBITORS
|
GB0318814D0
(en)
*
|
2003-08-11 |
2003-09-10 |
Smithkline Beecham Corp |
Novel compounds
|
US7244441B2
(en)
|
2003-09-25 |
2007-07-17 |
Scios, Inc. |
Stents and intra-luminal prostheses containing map kinase inhibitors
|
WO2005032481A2
(en)
|
2003-09-30 |
2005-04-14 |
Scios Inc. |
Quinazoline derivatives as medicaments
|
US7419978B2
(en)
*
|
2003-10-22 |
2008-09-02 |
Bristol-Myers Squibb Company |
Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
|
US7880017B2
(en)
*
|
2003-11-11 |
2011-02-01 |
Allergan, Inc. |
Process for the synthesis of imidazoles
|
US7183305B2
(en)
*
|
2003-11-11 |
2007-02-27 |
Allergan, Inc. |
Process for the synthesis of imidazoles
|
US7105707B2
(en)
*
|
2003-12-17 |
2006-09-12 |
Pharmacore, Inc. |
Process for preparing alkynyl-substituted aromatic and heterocyclic compounds
|
GB0402143D0
(en)
*
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|
TW200528101A
(en)
|
2004-02-03 |
2005-09-01 |
Astrazeneca Ab |
Chemical compounds
|
MY143245A
(en)
*
|
2004-04-28 |
2011-04-15 |
Mitsubishi Tanabe Pharma Corp |
4- 2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
|
KR100793479B1
(ko)
*
|
2004-04-28 |
2008-01-14 |
다나베 미츠비시 세이야꾸 가부시키가이샤 |
염증성 질환을 치료하기 위한 p38 MAP- 키나제억제제로서의4-2-(시클로알킬아미노)피리딘-4-일-(페닐)-이미다졸린-2-온 유도체
|
EP1751139B1
(de)
*
|
2004-04-30 |
2011-07-27 |
Bayer HealthCare LLC |
Substituierte pyrazolyl-harnstoff-derivate zur behandlung von krebs
|
WO2006115509A2
(en)
|
2004-06-24 |
2006-11-02 |
Novartis Vaccines And Diagnostics Inc. |
Small molecule immunopotentiators and assays for their detection
|
US7504521B2
(en)
*
|
2004-08-05 |
2009-03-17 |
Bristol-Myers Squibb Co. |
Methods for the preparation of pyrrolotriazine compounds
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
PE20060421A1
(es)
|
2004-08-12 |
2006-06-01 |
Bristol Myers Squibb Co |
Procedimiento para preparar un compuesto de pirrolotriazina anilina como inhibidores de cinasa
|
US20080051416A1
(en)
*
|
2004-10-05 |
2008-02-28 |
Smithkline Beecham Corporation |
Novel Compounds
|
JP2006182763A
(ja)
*
|
2004-12-03 |
2006-07-13 |
Daiso Co Ltd |
α,β−不飽和エステルの製法
|
PE20060777A1
(es)
|
2004-12-24 |
2006-10-06 |
Boehringer Ingelheim Int |
Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
|
EP1676574A3
(de)
|
2004-12-30 |
2006-07-26 |
Johnson & Johnson Vision Care, Inc. |
Verfahren zur Förderung des Überlebens von Zell- und Gewebe-Transplantaten
|
US20060178388A1
(en)
*
|
2005-02-04 |
2006-08-10 |
Wrobleski Stephen T |
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
|
GB0504753D0
(en)
*
|
2005-03-08 |
2005-04-13 |
Astrazeneca Ab |
Chemical compounds
|
KR20080002865A
(ko)
*
|
2005-03-25 |
2008-01-04 |
글락소 그룹 리미티드 |
피리도[2,3-d]피리미딘-7-온 및3,4-디히드로피리미도[4,5-d]피리미딘-2(1h)-온유도체의 제조 방법
|
TWI389690B
(zh)
|
2005-03-25 |
2013-03-21 |
Glaxo Group Ltd |
新穎化合物(一)
|
US20060235020A1
(en)
*
|
2005-04-18 |
2006-10-19 |
Soojin Kim |
Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein
|
GB0512429D0
(en)
*
|
2005-06-17 |
2005-07-27 |
Smithkline Beecham Corp |
Novel compound
|
US7473784B2
(en)
|
2005-08-01 |
2009-01-06 |
Bristol-Myers Squibb Company |
Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
|
DE102005048072A1
(de)
*
|
2005-09-24 |
2007-04-05 |
Bayer Cropscience Ag |
Thiazole als Fungizide
|
AR056556A1
(es)
|
2005-09-30 |
2007-10-10 |
Astrazeneca Ab |
Imidazo(1,2-a)piridina con actividad antiproliferacion celular
|
DE102006001161A1
(de)
*
|
2006-01-06 |
2007-07-12 |
Qiagen Gmbh |
Verfahren zum Nachweis von Cytosin-Methylierungen
|
BRPI0708644A2
(pt)
*
|
2006-03-07 |
2011-06-07 |
Bristol-Myers Squibb Company |
compostos de pró-fármaco de anilina de pirrolotriazina úteis como inibidores de cinase
|
JP2009533393A
(ja)
|
2006-04-12 |
2009-09-17 |
プロビオドルグ エージー |
酵素阻害薬
|
EP2083816A2
(de)
*
|
2006-10-27 |
2009-08-05 |
Brystol-Myers Squibb Company |
Heterocyclische amidverbindungen als kinasehemmer
|
US7943617B2
(en)
*
|
2006-11-27 |
2011-05-17 |
Bristol-Myers Squibb Company |
Heterobicyclic compounds useful as kinase inhibitors
|
EP1992344A1
(de)
|
2007-05-18 |
2008-11-19 |
Institut Curie |
P38 Alpha als therapeutisches Target für Erkrankungen, die mit einer FGFR3- Mutation assoziiert sind
|
WO2009155389A1
(en)
*
|
2008-06-20 |
2009-12-23 |
Bristol-Myers Squibb Company |
Triazolopyridine compounds useful as kinase inhibitors
|
EP2300466B1
(de)
|
2008-06-20 |
2014-08-06 |
Bristol-Myers Squibb Company |
Imidazopyridin- und imidazopyrazinverbindungen als kinasehemmer
|
WO2012031057A1
(en)
|
2010-09-01 |
2012-03-08 |
Bristol-Myers Squibb Company |
Bms- 582949 for the treatment of resistant rheumatic disease
|
CN113350353A
(zh)
|
2015-03-23 |
2021-09-07 |
墨尔本大学 |
呼吸性疾病的治疗
|
CN110753688A
(zh)
*
|
2017-05-03 |
2020-02-04 |
墨尔本大学 |
用于治疗呼吸系统疾病的化合物
|
US10342786B2
(en)
|
2017-10-05 |
2019-07-09 |
Fulcrum Therapeutics, Inc. |
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
|
CA3077499C
(en)
|
2017-10-05 |
2021-09-21 |
Fulcrum Therapeutics, Inc. |
P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
|
JP2022507118A
(ja)
*
|
2018-11-07 |
2022-01-18 |
ザ ユニヴァーシティー オブ メルボルン |
呼吸器疾患の処置のための化合物及び組成物
|
CA3209491A1
(en)
|
2021-03-15 |
2022-09-22 |
Saul Yedgar |
Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease
|